Showing posts with label HBI-8000 granted orphan drug designation in Japan for treatment of peripheral T-cell lymphoma. Show all posts
Showing posts with label HBI-8000 granted orphan drug designation in Japan for treatment of peripheral T-cell lymphoma. Show all posts
Monday, March 7, 2016

HBI-8000 granted orphan drug designation in Japan for treatment of peripheral T-cell lymphoma

›
HUYA Bioscience International (HUYA), Founder, CEO & Executive Chair, Dr. Mireille Gillings today announced that the Ministry of...